GluN2D-containing NMDA receptors inhibit neurotransmission in the mouse striatum through a cholinergic mechanism: Implication for Parkinson's disease

Journal of Neurochemistry

Volumn 129, Issue 4, 2014, Pages 581-590

  Zhang, Xiaoqun ^a   Feng, Ze Jun ^a   Chergui, Karima ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

acetylcholine; dopamine; GluN2D; glutamate; NMDA receptor; Parkinson's disease

Indexed keywords

1 (PHENANTHREN 2 CARBONYL)PIPERAZINE 2,3 DICARBOXYLIC ACID; 3,6A,11,14 TETRAHYDRO 9 METHOXY 2 METHYL 12H ISOQUINO[1,2 B]PYRROLO[3,2 F][1,3]BENZOXAZINE 1 CARBOXYLIC ACID ETHYL ESTER; DOPAMINE; GLUTAMIC ACID; J 104129; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2D; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OTENZEPAD; OXIDOPAMINE; OXOTREMORINE M; PIRENZEPINE; UBP 141; UNCLASSIFIED DRUG; UPB141;

AMPEROMETRY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINERGIC NERVE CELL; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DRUG MECHANISM; DRUG SELECTIVITY; ENZYME INHIBITION; MALE; MOUSE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL;

MUS;

ACETYLCHOLINE; DOPAMINE; GLUN2D; GLUTAMATE; NMDA RECEPTOR; PARKINSON'S DISEASE;

ACETYLCHOLINE; ACTION POTENTIALS; ANIMALS; CORPUS STRIATUM; DEPRESSION, CHEMICAL; DOPAMINE; GLUTAMIC ACID; INTERNEURONS; MALE; MICE; MICE, INBRED C57BL; MODELS, NEUROLOGICAL; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; OXIDOPAMINE; PARKINSONIAN DISORDERS; PATCH-CLAMP TECHNIQUES; RECEPTORS, N-METHYL-D-ASPARTATE; SECRETORY RATE; SYNAPTIC TRANSMISSION;

EID: 84899472421     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12658     Document Type: Article

References (43)

1. 2. J. Neurosci. 23, 2744-2750. (Pubitemid 36418609)
2. Bagetta V., Ghiglieri V., Sgobio C., Calabresi P., and, Picconi B., (2010) Synaptic dysfunction in Parkinson's disease. Biochem. Soc. Trans. 38, 493-497.
3. Bloomfield C., O'Donnell P., French S. J., and, Totterdell S., (2007) Cholinergic neurons of the adult rat striatum are immunoreactive for glutamatergic N-methyl-d-aspartate 2D but not N-methyl-d-aspartate 2C receptor subunits. Neuroscience 150, 639-646. (Pubitemid 350198727)
4. Bonsi P., Cuomo D., Martella G., Madeo G., Schirinzi T., Puglisi F., Ponterio G., and, Pisani A., (2011) Centrality of striatal cholinergic transmission in basal ganglia function. Front. Neuroanat. 5, 1-9.
5. Brothwell S. L. C., Barber J. L., Monaghan D. T., Jane D. E., Gibb A. J., and, Jones S., (2008) NR2B- and NR2D-containing synaptic NMDA receptors in developing rat substantia nigra pars compacta dopaminergic neurones. J. Physiol. 586, 739-750. (Pubitemid 351194114)
6. Cepeda C., and, Levine M. S., (2012) Dopamine-NMDA receptor interactions: twenty years later. Dev. Neurosci. 34, 2-4.
7. Cheramy A., L'Hirondel M., Godeheu G., Artaud F., and, Glowinski J., (1998) Direct and indirect presynaptic control of dopamine release by excitatory amino acids. Amino Acids 14, 63-68. (Pubitemid 28051153)
8. Chergui K., (2011) Dopamine induces a GluN2A-dependent form of long-term depression of NMDA synaptic responses in the nucleus accumbens. Neuropharmacology 60, 975-981.
9. Chergui K., Svenningsson P., and, Greengard P., (2004) Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum. Proc. Natl Acad. Sci. USA 101, 2191-2196. (Pubitemid 38229037)
10. Costa B. M., Feng B., Tsintsadze T. S., Morley R. M., Irvine M. W., Tsintsadze V., Lozovaya N. A., Jane D. E., and, Monaghan D. T., (2009) N-Methyl-d-aspartate (NMDA) receptor NR2 subunit selectivity of a series of novel piperazine-2,3-dicarboxylate derivatives: preferential blockade of extrasynaptic NMDA receptors in the rat hippocampal CA3-CA1 synapse. J. Pharmacol. Exp. Ther. 331, 618-626.
11. David H. N., Ansseau M., and, Abraini J. H., (2005) Dopamine-glutamate reciprocal modulation of release and motor responses in the rat caudate-putamen and nucleus accumbens of "intact" animals. Brain Res. Rev. 50, 336-360. (Pubitemid 41654400)
12. Dunah A. W., Wang Y., Yasuda R. P., Kameyama K., Huganir R. L., Wolfe B. B., and, Standaert D. G., (2000) Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease. Mol. Pharmacol. 57, 342-352. (Pubitemid 30084511)
13. Feng B., Tse H. W., Skifter D. A., Morley R., Jane D. E., and, Monaghan D. T., (2004) Structure-activity analysis of a novel NR2C/NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-carbonyl) piperazine-2,3-dicarboxylic acid. Br. J. Pharmacol. 141, 508-516. (Pubitemid 38297013)
14. Gardoni F., Picconi B., Ghiglieri V., Polli F., Bagetta V., Bernardi G., Cattabeni F., Di Luca M., and, Calabresi P., (2006) A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. J. Neurosci. 26, 2914-2922.
15. Gogas K. R., (2006) Glutamate-based therapeutic approaches: NR2B receptor antagonists. Curr. Opin. Pharmacol. 6, 68.
16. Goldberg J. A., Ding J. B., and, Surmeier D. J,. (2012) Muscarinic modulation of striatal function and circuitry. Handb. Exp. Pharmacol. 208, 223-241.
17. Harney S. C., and, Anwyl R., (2012) Plasticity of NMDA receptor-mediated excitatory postsynaptic currents at perforant path inputs to dendrite-targeting interneurons. J. Physiol. 590, 3771-3786.
18. Harney S. C., Jane D. E., and, Anwyl R., (2008) Extrasynaptic NR2D-containing NMDARs are recruited to the synapse during LTP of NMDAR-EPSCs. J. Neurosci. 28, 11685-11694.
19. Iravani M. M., and, Kruk Z. L., (1996) Real-time effects of N-methyl-D-aspartic acid on dopamine release in slices of rat caudate putamen: a study using fast cyclic voltammetry. J. Neurochem. 66, 1076-1085.
20. Jones S., and, Gibb A. J., (2005) Functional NR2B- and NR2D-containing NMDA receptor channels in rat substantia nigra dopaminergic neurones. J. Physiol. 569, 209-221. (Pubitemid 41701386)
21. Kawaguchi Y., (1993) Physiological, morphological, and histochemical characterization of 3 classes of interneurons in rat neostriatum. J. Neurosci. 13, 4908-4923. (Pubitemid 23326358)
22. Kayadjanian N., Schofield W. N., Andren J., Sirinathsinghji D. J. S., and, Besson M. J., (1999) Cortical and nigral deafferentation and striatal cholinergic markers in the rat dorsal striatum: different effects on the expression of mRNAs encoding choline acetyltransferase and muscarinic m1 and m4 receptors. Eur. J. Neurosci. 11, 3659-3668. (Pubitemid 29484262)
23. Krebs M. O., Desce J. M., Kemel M. L., Gauchy C., Godeheu G., Cheramy A., and, Glowinski J., (1991) Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J. Neurochem. 56, 81-85. (Pubitemid 21901933)
24. Landwehrmeyer G. B., Standaert D. G., Testa C. M., Penney J. B., Jr, and, Young A. B., (1995) NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. J. Neurosci. 15, 5297-5307.
25. Loftis J. M., and, Janowsky A., (2003) The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications. Pharmacol. Ther. 97, 55-85. (Pubitemid 35477804)
26. Ma Y.-Y., Cepeda C., and, Cui C.-L., (2009) The role of striatal nmda receptors in drug addiction. In: International Review of Neurobiology (, Adron Harris R., and, Jenner P., eds.) Vol. 89, pp. 131-146. Elsevier Inc., Amsterdam, the Netherlands.
27. Moghaddam B., and, Javitt D., (2012) From revolution to evolution: The glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology 37, 4-15.
28. Ohta K., Araki N., Shibata M., Komatsumoto S., Shimazu K., and, Fukuuchi Y., (1994) Presynaptic ionotropic glutamate receptors modulate in vivo release and metabolism of striatal dopamine, noradrenaline, and 5-hydroxytryptamine: involvement of both NMDA and AMPA/kainate subtypes. Neurosci. Res. 21, 83-89.
29. Paille V., Picconi B., Bagetta V., et al,. (2010) Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition. J. Neurosci. 30, 14182-14193.
30. Paoletti P., Bellone C., and, Zhou Q., (2013) NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat. Rev. Neurosci. 14, 383-400.
31. Paxinos G., and, Franklin K. B. J., (2001) The Mouse Brain in Stereotaxic Coordinates. Academic, San Diego.
32. Pisani A., Bernardi G., Ding J., and, Surmeier D. J., (2007) Re-emergence of striatal cholinergic interneurons in movement disorders. Trends Neurosci. 30, 545-553. (Pubitemid 47513239)
33. Rice M. E., Patel J. C., and, Cragg S. J., (2011) Dopamine release in the basal ganglia. Neuroscience 198, 112-137.
34. Schotanus S., and, Chergui K., (2008) NR2A-containing NMDA receptors depress glutamatergic synaptic transmission and evoked-dopamine release in the mouse striatum. J. Neurochem. 106, 1758-1765.
35. Schotanus S. M., Fredholm B. B., and, Chergui K., (2006) NMDA depresses glutamatergic synaptic transmission in the striatum through the activation of adenosine A1 receptors: evidence from knockout mice. Neuropharmacology 51, 272-282. (Pubitemid 44061891)
36. Standaert D. G., Testa C. M., Young A. B., and, Penney J. B., Jr, (1994) Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat. J. Comp. Neurol. 343, 1-16. (Pubitemid 24129523)
37. Standaert D. G., Landwehrmeyer G. B., Kerner J. A., Penney J. B., Jr, and, Young A. B., (1996) Expression of NMDAR2D glutamate receptor subunit mRNA in neurochemically identified interneurons in the rat neostriatum, neocortex and hippocampus. Brain Res. Mol. Brain Res. 42, 89-102. (Pubitemid 26345410)
38. Standaert D. G., Friberg I. K., Landwehrmeyer G. B., Young A. B., and, Penney J. B., (1999) Expression of NMDA glutamate receptor subunit mRNAs in neurochemically identified projection and interneurons in the striatum of the rat. Mol. Brain Res. 64, 11-23. (Pubitemid 29049231)
39. Threlfell S., Clements M. A., Khodai T., Pienaar I. S., Exley R., Wess J., and, Cragg S. J., (2010) Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum. J. Neurosci. 30, 3398-3408.
40. Tozzi A., de Iure A., Di Filippo M., et al,. (2011) The distinct role of medium spiny neurons and cholinergic interneurons in the D2/A2A receptor interaction in the striatum: implications for Parkinson's disease. J. Neurosci. 31, 1850-1862.
41. Zhang X., and, Chergui K., (2011) P.1.015 GluN2D-containing NMDA receptors in cholinergic interneurons control dopamine release in the mouse striatum. Eur. Neuropsychopharmacol. 21, S14-S15.
42. Zhang H., and, Sulzer D., (2012) Regulation of striatal dopamine release by presynaptic auto-and heteroreceptors. Basal Ganglia 2, 5-13.
43. Zhang X., Andren P. E., Greengard P., and, Svenningsson P., (2008) Evidence for a role of the 5-HT1B receptor and its adaptor protein, p11, in l-DOPA treatment of an animal model of Parkinsonism. Proc. Natl Acad. Sci. USA 105, 2163-2168. (Pubitemid 351439482)